Severe COVID-19 Can Alter Long-term Immune System Response

Immunology Interest Group (IIG) Seminar Series Archive

ISB Researchers Find a Chink in the Armor of Tuberculosis Pathogen

Exavir Therapeutics Receives $3 Million Award from NIH / NIAID to Advance Ultra-Long-Acting Integrase Inhibitor XVIR-110

Media Type
Article
Publish or Event Date
Research Institution
Exavir Therapeutics
Short Title
Exavir Therapeutics Receives $3 Million Award from NIH / NIAID to Advance Ultra-Long-Acting Integrase Inhibitor XVIR-110
Content Coordinator

U of M Research Team Successfully Tests New Antifungal Therapy for Fungal Meningitis

Heavy Rain + High Temps Means Greater Risk of Valley Fever

Blocking the Paths to Viral Infection

Media Type
Article
Publish or Event Date
Research Institution
University of Pittsburgh
Short Title
Blocking the Paths to Viral Infection
Content Coordinator

IMUNON Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus

Media Type
Article
Publish or Event Date
Research Institution
IMUNON, Inc.
Short Title
IMUNON Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus
Content Coordinator

Resistant E. coli Rises Despite Drop in Ciprofloxacin Use

Media Type
Article
Publish or Event Date
Research Institution
University of Washington School of Medicine
Short Title
Resistant E. coli Rises Despite Drop in Ciprofloxacin Use
Content Coordinator

COVID-19 Virus Is Evolving Rapidly in White-Tailed Deer